KCM
PRCT icon

Kornitzer Capital Management’s Procept Biorobotics PRCT Stock Holding History

Kornitzer Capital Management’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-42,735
Closed -$1.07M – 577
2026
Q1 		$1.07M Hold
42,735
– – 0.02% 375
2025
Q4 		$1.34M Hold
42,735
– – 0.03% 365
2025
Q3 		$1.53M Hold
42,735
– – 0.03% 350
2025
Q2 		$2.46M Buy
+42,735
New +$2.42M 0.05% 306

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Kornitzer Capital Management's PRCT Position: Q2 2026 in Review

Kornitzer Capital Management sold out of Procept Biorobotics (PRCT) in Q2 2026, closing a stake of 42,735 shares — an estimated $1.07M sold.

Kornitzer Capital Management first reported a position in PRCT in Q2 2025 and held it in 4 quarters. The position peaked at $2.46M in Q2 2025. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Kornitzer Capital Management reported no remaining Procept Biorobotics position as of Q2 2026 after selling out during the quarter.
  • Kornitzer Capital Management sold 42,735 Procept Biorobotics shares in Q2 2026, an estimated $1.07M.
  • Kornitzer Capital Management first reported a position in Procept Biorobotics in Q2 2025 and held it in 4 quarters.
  • Kornitzer Capital Management's Procept Biorobotics position peaked at $2.46M in Q2 2025.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Kornitzer Capital Management's 13F filing for Q2 2026, filed 31 Jul 2026.